MONTREAL--(BUSINESS WIRE)--Feb. 21, 2006--ProMetic Life Sciences Inc. (TSX:PLI.SV) (“ProMetic” or the “Company”), a leading biopharmaceutical company, today updates the financial community on its progress related to the corporate reorganization announced in November 2005. The Company is restructuring as a parent company with four pure-play operating units. Each distinct unit is pursuing a focused business plan and is pursuing funding opportunities with investors looking for a specific risk/return profile.
